Telomeres Length in Israeli Fibrotic ILD Patients

Individuals with fibrotic interstitial lung diseases (FILD) will be recruited after providing informed consent. in addition to routine data as usually collected in the clinic, blood samples will be taken for measurement of telomeres length in peripheral blood leukocytes using both the Telomere Restriction Fragment (TRF) Analysis method and Nanopore sequencing. Participants with FILD will be followed-up for 2-year after recruitment, including clinical and pulmonary function tests at-least every 6 months, or more frequently, according to the treating physician discretion.

NCT Number	NCT06885515
Lead Sponsor	Barzilai Medical Center Collaborators: Tel Aviv Medical Center, Israel Society of Pulmonology
Conditions	Pulmonary Fibrosis
Enrollment	100 participants
Start Date	2026-02
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-02-25